Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA Action
Written By : Parthika Patel
Published On 2026-01-06 09:41 GMT | Update On 2026-01-06 09:41 GMT
Advertisement
Chandigarh: The Haryana government has forwarded 33 cases of alleged overcharging of medicines to the National Pharmaceutical Pricing Authority (NPPA) in 2025 for further examination and action.
According to a recent media report in The Times of India, the cases involve complaints of medicines being sold above the ceiling prices fixed under the Drug (Prices Control) Order, 2013, and were identified through routine inspections and complaint-based scrutiny carried out by state drug control authorities. The referrals have been made to enable detailed investigation and enforcement under the central pricing mechanism.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.